G Fedeli
Overview
Explore the profile of G Fedeli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
396
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scrivano M, Fedeli G, Porcino S, Sinno E, Vadala A, Clarioni A, et al.
Injury
. 2024 Nov;
55 Suppl 4:111496.
PMID: 39542580
Introduction: Internal fixation in not-comminuted oblique and transverse olecranon fractures is commonly performed with tension band wiring. However, despite its high healing rate, this technique is associated with a high...
2.
Scrivano M, Vadala A, Fedeli G, Di Niccolo R, Topa D, Porcino S, et al.
Injury
. 2023 Nov;
55(2):111166.
PMID: 37984012
Introduction: Pelvis fractures are among the most difficult fractures to manage and treat for Orthopedic surgeons. Anatomic reduction is the main goal to reach in the acetabular fractures' treatment. The...
3.
Guidi L, Ratto C, Semeraro S, Roberto I, De Vitis I, Papa A, et al.
Tech Coloproctol
. 2008 Jun;
12(2):111-7.
PMID: 18545878
During infliximab treatment of perianal Crohn's disease (CD), the healing of the skin opening precedes fistula tract healing and this contributes to abscess formation and fistula recurrence. The aims of...
4.
Guidi L, De Franco A, De Vitis I, Armuzzi A, Semeraro S, Roberto I, et al.
Eur Rev Med Pharmacol Sci
. 2006 Feb;
10(1):23-6.
PMID: 16494107
The introduction of biological treatments like monoclonal anti TNF-a antibodies (infliximab), is changing the clinical history of Crohn's disease (CD). The effects of these therapies are monitored emplying clinical indexes...
5.
Papa A, Danese S, Urgesi R, Grillo A, Guglielmo S, Roberto I, et al.
Eur Rev Med Pharmacol Sci
. 2006 Feb;
10(1):7-11.
PMID: 16494104
Patients with inflammatory bowel disease (IBD) have an increased risk of thrombotic complications. Arterial and venous system may be involved. Moreover, mesenteric microvascular thrombosis has been hypothesised as a contributing...
6.
Danese S, Papa A, Scaldaferri F, Graziani C, Bonizzi M, Armuzzi A, et al.
Eur Rev Med Pharmacol Sci
. 2006 Feb;
10(1):3-5.
PMID: 16494103
Crohn's disease (CD) and ulcerative colitis (UC) are the two major forms of inflammatory bowel disease (IBD). Although their etiology is still unknown, the pathogenic mechanisms underlying intestinal inflammation have...
7.
Papa A, Santoliquido A, Danese S, Covino M, Di Campli C, Urgesi R, et al.
Aliment Pharmacol Ther
. 2005 Oct;
22(9):839-46.
PMID: 16225493
Background: Patients with inflammatory bowel disease have an increased risk of thrombotic complications; moreover, mesenteric microvascular thrombosis has been hypothesized as a contributing factor in the pathogenesis of inflammatory bowel...
8.
Papa A, Urgesi R, Grillo A, Danese S, Guglielmo S, Roberto I, et al.
Minerva Gastroenterol Dietol
. 2005 Feb;
50(3):215-26.
PMID: 15729197
Up to 70% of patients with typical symptoms of gastroesophageal reflux disease (GERD) have neither definite endoscopic oesophageal breaks nor Barrett's oesophagus at upper endoscopy. These patients suffer from non-erosive...
9.
Guidi L, Costanzo M, Ciarniello M, De Vitis I, Pioli C, Gatta L, et al.
Int J Immunopathol Pharmacol
. 2005 Feb;
18(1):155-64.
PMID: 15698520
The treatment with infliximab is employed successfully in Crohn's disease (CD) but predictors of efficacy are lacking. Activation of the transcription factor NF-kB has been demonstrated in CD and its...
10.
Guidi L, Minordi L, Semeraro S, De Vitis I, Roberto I, Ennas S, et al.
Eur Rev Med Pharmacol Sci
. 2005 Jan;
8(5):215-7.
PMID: 15638233
Backgrounds And Objective: Aim of the present study was to evaluate the clinical correlates of small bowel CT patterns in patients with Crohn's disease (CD), as compared to barium studies...